Chemservice Group, a provider of regulatory compliance services for the chemical industry and regulated sectors including cosmetics, has acquired EBRC Consulting. This marks the company's first acquisition since Waterland Private Equity invested in July 2025. The deal strengthens Chemservice's capabilities in European chemicals regulation, product safety, and toxicology—key areas for medical aesthetics importers and distributors navigating EU compliance for cosmetic ingredients and finished products.
Acquisition details
EBRC Consulting specializes in regulatory assessment, substance evaluation, dossier preparation, risk assessment, (eco)toxicology, and product safety. Its expertise covers industrial chemicals, metals, plant protection products, biocides, food additives, and cosmetics. The Hanover site, EBRC brand, and existing management team led by Dr. Rudiger Battersby will remain unchanged. Financial terms were not disclosed.
Strategic rationale
Chemservice CEO Dieter Drohmann stated that the acquisition strengthens the company in regulatory compliance, product safety, toxicology, risk assessment, European chemicals regulation, and consortia management. The combined entity aims to become one of Europe's leading specialist providers in this market. Further acquisitions and organic growth are planned.
What buyers should watch
For overseas importers, distributors, and clinic buyers of medical aesthetics products, this consolidation signals enhanced regulatory support for cosmetics compliance under EU frameworks such as REACH and CLP. Companies sourcing cosmetic ingredients or finished products from Europe can expect more streamlined dossier preparation and risk assessment services, potentially reducing time-to-market and compliance costs.
Source: Read the original report | Published: June 14, 2026